Logo image of BN.PA

DANONE (BN.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:BN - FR0000120644 - Common Stock

77.58 EUR
+0.22 (+0.28%)
Last: 1/13/2026, 5:35:30 PM
Fundamental Rating

5

Overall BN gets a fundamental rating of 5 out of 10. We evaluated BN against 63 industry peers in the Food Products industry. BN scores excellent on profitability, but there are some minor concerns on its financial health. While showing a medium growth rate, BN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year BN was profitable.
In the past year BN had a positive cash flow from operations.
Each year in the past 5 years BN has been profitable.
In the past 5 years BN always reported a positive cash flow from operatings.
BN.PA Yearly Net Income VS EBIT VS OCF VS FCFBN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.20%, BN is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
Looking at the Return On Equity, with a value of 11.59%, BN is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
BN has a Return On Invested Capital of 6.83%. This is in the better half of the industry: BN outperforms 65.08% of its industry peers.
BN had an Average Return On Invested Capital over the past 3 years of 6.38%. This is in line with the industry average of 6.78%.
The 3 year average ROIC (6.38%) for BN is below the current ROIC(6.83%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.2%
ROE 11.59%
ROIC 6.83%
ROA(3y)2.83%
ROA(5y)3.44%
ROE(3y)7.34%
ROE(5y)9%
ROIC(3y)6.38%
ROIC(5y)6.21%
BN.PA Yearly ROA, ROE, ROICBN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 6.72%, BN is doing good in the industry, outperforming 71.43% of the companies in the same industry.
BN's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 13.25%, BN is in the better half of the industry, outperforming 79.37% of the companies in the same industry.
BN's Operating Margin has declined in the last couple of years.
BN's Gross Margin of 50.47% is amongst the best of the industry. BN outperforms 82.54% of its industry peers.
In the last couple of years the Gross Margin of BN has remained more or less at the same level.
Industry RankSector Rank
OM 13.25%
PM (TTM) 6.72%
GM 50.47%
OM growth 3Y-1.81%
OM growth 5Y-3.08%
PM growth 3Y-1.94%
PM growth 5Y-0.54%
GM growth 3Y1.56%
GM growth 5Y0.26%
BN.PA Yearly Profit, Operating, Gross MarginsBN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BN is still creating some value.
The number of shares outstanding for BN has been increased compared to 1 year ago.
The number of shares outstanding for BN has been reduced compared to 5 years ago.
Compared to 1 year ago, BN has an improved debt to assets ratio.
BN.PA Yearly Shares OutstandingBN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BN.PA Yearly Total Debt VS Total AssetsBN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 2.55 indicates that BN is not a great score, but indicates only limited risk for bankruptcy at the moment.
BN has a better Altman-Z score (2.55) than 66.67% of its industry peers.
The Debt to FCF ratio of BN is 5.07, which is a neutral value as it means it would take BN, 5.07 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.07, BN is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
BN has a Debt/Equity ratio of 0.83. This is a neutral value indicating BN is somewhat dependend on debt financing.
The Debt to Equity ratio of BN (0.83) is worse than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 5.07
Altman-Z 2.55
ROIC/WACC1.06
WACC6.45%
BN.PA Yearly LT Debt VS Equity VS FCFBN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

BN has a Current Ratio of 0.95. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
BN's Current ratio of 0.95 is on the low side compared to the rest of the industry. BN is outperformed by 71.43% of its industry peers.
BN has a Quick Ratio of 0.95. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
BN has a Quick ratio (0.78) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.78
BN.PA Yearly Current Assets VS Current LiabilitesBN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

BN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.47%.
Measured over the past years, BN shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.17% on average per year.
Looking at the last year, BN shows a small growth in Revenue. The Revenue has grown by 0.54% in the last year.
BN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.60% yearly.
EPS 1Y (TTM)4.47%
EPS 3Y3.12%
EPS 5Y-1.17%
EPS Q2Q%6.11%
Revenue 1Y (TTM)0.54%
Revenue growth 3Y4.08%
Revenue growth 5Y1.6%
Sales Q2Q%-0.15%

3.2 Future

The Earnings Per Share is expected to grow by 6.09% on average over the next years.
Based on estimates for the next years, BN will show a small growth in Revenue. The Revenue will grow by 2.86% on average per year.
EPS Next Y7.99%
EPS Next 2Y7.4%
EPS Next 3Y7.7%
EPS Next 5Y6.09%
Revenue Next Year0.7%
Revenue Next 2Y1.88%
Revenue Next 3Y2.56%
Revenue Next 5Y2.86%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BN.PA Yearly Revenue VS EstimatesBN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B
BN.PA Yearly EPS VS EstimatesBN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

BN is valuated rather expensively with a Price/Earnings ratio of 20.74.
BN's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.25, BN is valued a bit cheaper.
The Price/Forward Earnings ratio is 18.53, which indicates a rather expensive current valuation of BN.
Based on the Price/Forward Earnings ratio, BN is valued a bit more expensive than the industry average as 61.90% of the companies are valued more cheaply.
BN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.98.
Industry RankSector Rank
PE 20.74
Fwd PE 18.53
BN.PA Price Earnings VS Forward Price EarningsBN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BN.
BN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 18.43
EV/EBITDA 11.11
BN.PA Per share dataBN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BN may justify a higher PE ratio.
PEG (NY)2.6
PEG (5Y)N/A
EPS Next 2Y7.4%
EPS Next 3Y7.7%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.82%, BN has a reasonable but not impressive dividend return.
BN's Dividend Yield is a higher than the industry average which is at 2.42.
BN's Dividend Yield is a higher than the S&P500 average which is at 1.92.
Industry RankSector Rank
Dividend Yield 2.82%

5.2 History

The dividend of BN has a limited annual growth rate of 1.58%.
Dividend Growth(5Y)1.58%
Div Incr Years3
Div Non Decr Years4
BN.PA Yearly Dividends per shareBN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

74.99% of the earnings are spent on dividend by BN. This is not a sustainable payout ratio.
The dividend of BN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP74.99%
EPS Next 2Y7.4%
EPS Next 3Y7.7%
BN.PA Yearly Income VS Free CF VS DividendBN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
BN.PA Dividend Payout.BN.PA Dividend Payout, showing the Payout Ratio.BN.PA Dividend Payout.PayoutRetained Earnings

DANONE

EPA:BN (1/13/2026, 5:35:30 PM)

77.58

+0.22 (+0.28%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)10-07 2025-10-07
Earnings (Next)02-20 2026-02-20/amc
Inst Owners54.21%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap52.86B
Revenue(TTM)27.36B
Net Income(TTM)1.84B
Analysts75.33
Price Target80.89 (4.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.82%
Yearly Dividend2.1
Dividend Growth(5Y)1.58%
DP74.99%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.16%
Valuation
Industry RankSector Rank
PE 20.74
Fwd PE 18.53
P/S 1.93
P/FCF 18.43
P/OCF 13.74
P/B 3.33
P/tB N/A
EV/EBITDA 11.11
EPS(TTM)3.74
EY4.82%
EPS(NY)4.19
Fwd EY5.4%
FCF(TTM)4.21
FCFY5.43%
OCF(TTM)5.64
OCFY7.28%
SpS40.15
BVpS23.28
TBVpS-9.5
PEG (NY)2.6
PEG (5Y)N/A
Graham Number44.26
Profitability
Industry RankSector Rank
ROA 4.2%
ROE 11.59%
ROCE 12.02%
ROIC 6.83%
ROICexc 8.36%
ROICexgc 50.58%
OM 13.25%
PM (TTM) 6.72%
GM 50.47%
FCFM 10.49%
ROA(3y)2.83%
ROA(5y)3.44%
ROE(3y)7.34%
ROE(5y)9%
ROIC(3y)6.38%
ROIC(5y)6.21%
ROICexc(3y)7.67%
ROICexc(5y)7.39%
ROICexgc(3y)52.44%
ROICexgc(5y)45.6%
ROCE(3y)10.98%
ROCE(5y)10.58%
ROICexgc growth 3Y19.7%
ROICexgc growth 5Y13.36%
ROICexc growth 3Y4.65%
ROICexc growth 5Y1.26%
OM growth 3Y-1.81%
OM growth 5Y-3.08%
PM growth 3Y-1.94%
PM growth 5Y-0.54%
GM growth 3Y1.56%
GM growth 5Y0.26%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 5.07
Debt/EBITDA 2.71
Cap/Depr 77.72%
Cap/Sales 3.57%
Interest Coverage 23.53
Cash Conversion 78.8%
Profit Quality 156.01%
Current Ratio 0.95
Quick Ratio 0.78
Altman-Z 2.55
F-Score8
WACC6.45%
ROIC/WACC1.06
Cap/Depr(3y)59.49%
Cap/Depr(5y)65.43%
Cap/Sales(3y)3.2%
Cap/Sales(5y)3.59%
Profit Quality(3y)220.86%
Profit Quality(5y)178.79%
High Growth Momentum
Growth
EPS 1Y (TTM)4.47%
EPS 3Y3.12%
EPS 5Y-1.17%
EPS Q2Q%6.11%
EPS Next Y7.99%
EPS Next 2Y7.4%
EPS Next 3Y7.7%
EPS Next 5Y6.09%
Revenue 1Y (TTM)0.54%
Revenue growth 3Y4.08%
Revenue growth 5Y1.6%
Sales Q2Q%-0.15%
Revenue Next Year0.7%
Revenue Next 2Y1.88%
Revenue Next 3Y2.56%
Revenue Next 5Y2.86%
EBIT growth 1Y3.81%
EBIT growth 3Y2.2%
EBIT growth 5Y-1.53%
EBIT Next Year35.93%
EBIT Next 3Y14.73%
EBIT Next 5Y10.6%
FCF growth 1Y12.42%
FCF growth 3Y6.14%
FCF growth 5Y3.12%
OCF growth 1Y12.55%
OCF growth 3Y3.31%
OCF growth 5Y2.15%

DANONE / BN.PA FAQ

What is the ChartMill fundamental rating of DANONE (BN.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to BN.PA.


What is the valuation status for BN stock?

ChartMill assigns a valuation rating of 3 / 10 to DANONE (BN.PA). This can be considered as Overvalued.


How profitable is DANONE (BN.PA) stock?

DANONE (BN.PA) has a profitability rating of 7 / 10.


What are the PE and PB ratios of DANONE (BN.PA) stock?

The Price/Earnings (PE) ratio for DANONE (BN.PA) is 20.74 and the Price/Book (PB) ratio is 3.33.


What is the earnings growth outlook for DANONE?

The Earnings per Share (EPS) of DANONE (BN.PA) is expected to grow by 7.99% in the next year.